| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |